|
Summary: Applied Pharmacoeconomic and
Outcomes Research Forum
February 3rd 2012
1. AMCP Dossiers: Useful for Decision Making or Not? A Debate
2. Biologics: Drawing (or Crossing) the line of Cost vs. Benefit: A
Case in Oncology
3. Quality Adjusted Life Years (QALY's) for Decision Making: Views
from Canada & the US
4. Using Large Databases to Inform Decision Making: Experience
in Three Health Care Systems
5. Real World Data for Decision Making: Moving Beyond Clinical
Trials
6. Pharmacoeconomics of Pharmacogenomics
7. Pharmacoeconomics & Pricing: Now & After Health Care Reform
8.What is the Business Case for Quality
Improvement Initiatives?
Eight Forums and Five Years ...
· Discuss commonly encountered obstacles to
conducting or utilizing results of PE studies for
decision making
|
